Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:50 PM
Ignite Modification Date:
2025-12-24 @ 9:50 PM
NCT ID:
NCT01631032
Eligibility Criteria:
Inclusion Criteria:
* Patients with one or more following symptoms: nose itching, sneezing, rhinorrhea with clear nasal discharge, stuffy nose.
* exacerbation times less than 4 days a week or consecutive episodes less than four weeks
* Mite allergy confirmed by Childhood Allergy Panel (CAP)
Exclusion Criteria:
* Use of steroid, antihistamine, Montelukast or other immuno-modulation drugs or duration of drug discontinuation less than one month
* Active infection, including sinusitis
* Vasomotor rhinitis
* Unable to swallow capsule or history of poor medication compliance
* Major organ dysfunction with relevant impaired physical performance status
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
50 Years
Study:
NCT01631032
Study Brief:
Protocol Section:
NCT01631032